Document is current
Any future updates will be listed below
-
Authors
Clark, Kristen D.
Lunn, Mitchell R.
Bosse, Jordon D.
Sevelius, Jae M.
Dawson-Rose, Carol
Weiss, Sandra J.
Lubensky, Micah E.
Obedin-Maliver, Juno
Flentje, Annesa
-
Funding
Funding for this research was provided by:
Uppsala University
- License Information
-
More Information
Article History
Received: 13 July 2022
Accepted: 26 July 2023
First Online: 24 August 2023
Declarations
:
: JOM has consulted for Sage Therapeutics (5/2017) in a one-day advisory board, Ibis Reproductive Health (a non-for-profit research group; 3/2017-5/2018, 2020-present), Hims Inc. (2019 - present), and Folx Inc (2020-present). MRL has consulted for Hims Inc. (2019 - present) and Folx, Inc. (2020). The remaining authors have no conflicts to disclose.
: This study was reviewed and approved by the Stanford University and University of California San Francisco institutional review boards. Upon enrollment in The PRIDE Study, participants were provided with informed consent which they then affirmed electronically.
: Not applicable.
